Stockreport

SNTI Stock Skyrockets on Initial Data From Phase I Cancer Study [Yahoo! Finance]

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF therapy candidate, SENTI-202, for the treatment of relapsed/refractory hematologic malignancies, including acute myeloid leukemia (AML). Shares of the company skyrocke [Read more]